Bernie Sanders Addresses Corporate Greed in Drug Pricing of Ozempic and Wegovy
Senator Sanders Confronts Big Pharma Over Drug Prices
In a recent panel discussion, Bernie Sanders criticized corporate greed exhibited by big pharma, specifically targeting Novo Nordisk for its pricing of Ozempic.
Impact of Drug Prices on Patients
Sanders articulated the burden that inflated drug prices impose on American patients. The cost of Ozempic approaches $900 a month, while generic alternatives could be provided at a fraction of that cost, around $100 or even less.
- Sanders revealed that a study indicates the manufacturing cost for the drug is under $5.
- He has engaged with pharmaceutical executives, urging them to consider affordable options for patients.
Public Citizen and Legislative Action
Sanders, aligned with advocacy groups like Public Citizen, continues to push for action from the Senate Help Committee to address this pressing issue.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.